Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas

SIMPLE SUMMARY: New therapies for lymphoma continue to be developed at a rapid rate, including for the indolent lymphomas. While traditional cytotoxic chemotherapy remains an effective treatment option, many new treatments target specific aspects of cancer cells such as surface proteins or signaling...

Descripción completa

Detalles Bibliográficos
Autores principales: Minson, Adrian, Tam, Constantine, Dickinson, Michael, Seymour, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908980/
https://www.ncbi.nlm.nih.gov/pubmed/35267584
http://dx.doi.org/10.3390/cancers14051276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908980/
https://www.ncbi.nlm.nih.gov/pubmed/35267584
http://dx.doi.org/10.3390/cancers14051276

Ejemplares similares